On Saturday 3 April, Algeria received 360,000 doses of COVID-19 vaccine through the COVAX Facility. This delivery is part of a provisional allocation of more than 2.2 million doses that will continue during the year.
” My colleagues from the Member States and I are delighted with the concretization of this mechanism, to which the European Union contributes massively, showing that international solidarity in the fight against the global pandemic is not an empty word, especially at this time where all our governments are facing the challenge of vaccine availability in this race against time while confronting a new wave “, stated the Ambassador of the European Union to Algeria John O’Rourke.
COVAX is a global facility representing partnership between the World Health Organization (WHO), Global Alliance for Vaccines and Immunization (GAVI) and the Coalition for Epidemic Preparedness Innovations (CEPI) working on the equitable distribution of COVID-19 vaccines. It includes 190 countries with population of more than 7 billion people and ensures fair and equal access to COVID-19 vaccines supplied through UNICEF.
From the start, the EU and its Member States (Team Europe) contributed €2.2 billion to this mechanism to ensure WHO-approved vaccine doses in 92 low- and middle-income countries to make COVID-19 vaccines a global public good.